Is Erythromycin (erythromycin) eye ointment effective for treating coliform infections of the eye?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Erythromycin Eye Ointment for Coliform Infections

Erythromycin eye ointment is not recommended as first-line therapy for coliform (gram-negative) ocular infections as fluoroquinolones are more effective against these pathogens. 1

Recommended Treatment Approach for Coliform Eye Infections

First-line Treatment Options

  • Topical fluoroquinolones are recommended as first-line therapy for bacterial keratitis caused by gram-negative organisms like coliforms due to their broad-spectrum coverage 1
  • Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) provide excellent coverage against gram-negative pathogens while offering improved gram-positive coverage compared to earlier generations 1
  • Fluoroquinolones have been shown to be as effective as combination fortified antibiotic therapy for bacterial keratitis in multiple clinical trials 1, 2

Alternative Treatment Options

  • For severe infections or cases unresponsive to initial therapy, combination fortified-antibiotic therapy should be considered 1
  • Aminoglycosides (gentamicin, tobramycin) provide good coverage against gram-negative bacteria including coliforms and may be used in combination with other agents 1, 3
  • For multidrug-resistant Pseudomonas (a gram-negative organism), topical colistin 0.19% may be considered 1

Treatment Administration

  • For severe or central corneal infections, aggressive dosing is required - loading doses every 5-15 minutes followed by hourly applications 2
  • Frequency of reevaluation depends on severity - severe cases should be followed daily initially until clinical improvement is confirmed 1
  • For lesions close to the limbus, consider additional use of systemic antibiotics 1

Efficacy Considerations

  • A Cochrane review found no evidence of difference in corneal perforation rates between different classes of topical antibiotics 1
  • Fluoroquinolones are associated with reduced eye discomfort compared to aminoglycoside-cephalosporin combinations 1
  • Single-drug therapy using fluoroquinolones has been shown to be as effective as combination therapy utilizing fortified antibiotics 2

Important Caveats

  • Resistance patterns should be considered - there has been increasing resistance to fluoroquinolones in some regions (e.g., P. aeruginosa resistance to moxifloxacin increased from 19% to 52% in southern India) 1
  • Erythromycin, while effective for some gram-positive infections and commonly used in neonatal prophylaxis, has limited activity against gram-negative organisms like coliforms 4, 3
  • Fortified antibiotics should be prepared by a compounding pharmacy that is a member of the Pharmacy Compounding Accreditation Board and designated by the FDA as a 503A and/or 503B facility 1
  • Risk factors for fluoroquinolone resistance include recent fluoroquinolone use, hospitalization, advanced age, and recent ocular surgery 2

Monitoring and Follow-up

  • Severe cases (deep stromal involvement or infiltrates larger than 2 mm with extensive suppuration) require daily follow-up initially 1
  • Consider culture and sensitivity testing if the infection does not respond to initial therapy 5
  • Topical corticosteroid therapy may be considered after initial control of infection to reduce inflammation and subsequent corneal scarring 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ofloxacin Therapy for Ocular Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.